The markets opened mixed with the Dow losing 20 points to 18,233 while Nasdaq added 8 points to 5,308 as crude oil prices slipped.
On the upside
SeaDrill's (NYSE: SDRL) largest shareholder and chairman John Fredriksen offered to lend the company up to $1.2 billion as part of a deal to restructure debt.
Summit Therapeutics (Nasdaq: SMMT) entered an exclusive license and collaboration agreement granting Sarepta Therapeutics (Nasdaq: SRPT) rights in Europe, as well as Turkey and the Commonwealth of Independent States to Summit's utrophin modulator pipeline.
Aralez Pharmaceuticals (Nasdaq: ARLZ) will acquire the U.S. rights to Toprol-XL and its Authorized Generic from AstraZeneca (NYSE: AZN).
On the downside
Trinity Biotech (Nasdaq: TRIB) withdrew its 510(k) premarket notification submission for the Meritas Troponin-I Test and the Meritas Point-of-Care Analyzer.
Investors locked in profits on Versum Materials (NYSE: VSM).
Profit taking weighed down shares of Nova Lifestyle (Nasdaq: NVFY).
In the broad market, advancing issues barely edged out decliners by a slim margin on the NYSE and by 3 to 2 on Nasdaq. The broader S&P 500 slipped 3 points to 2,157. Bitcoin eased a fraction to $609.
